SE0004892D0 - Group 2 allergen specific IgE-Fabs and use thereof - Google Patents

Group 2 allergen specific IgE-Fabs and use thereof

Info

Publication number
SE0004892D0
SE0004892D0 SE0004892A SE0004892A SE0004892D0 SE 0004892 D0 SE0004892 D0 SE 0004892D0 SE 0004892 A SE0004892 A SE 0004892A SE 0004892 A SE0004892 A SE 0004892A SE 0004892 D0 SE0004892 D0 SE 0004892D0
Authority
SE
Sweden
Prior art keywords
fabs
specific ige
group
allergen specific
relates
Prior art date
Application number
SE0004892A
Other languages
English (en)
Swedish (sv)
Inventor
Sabine Flicker
Peter Steinberger
Dietrich Kraft
Rudolf Valenta
Original Assignee
Pharmacia Diagnostics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Diagnostics Ab filed Critical Pharmacia Diagnostics Ab
Priority to SE0004892A priority Critical patent/SE0004892D0/xx
Publication of SE0004892D0 publication Critical patent/SE0004892D0/xx
Priority to US10/027,725 priority patent/US7288381B2/en
Priority to EP01273005A priority patent/EP1351988B1/en
Priority to DE60135677T priority patent/DE60135677D1/de
Priority to JP2002555117A priority patent/JP2004532813A/ja
Priority to ES01273005T priority patent/ES2315259T3/es
Priority to AT01273005T priority patent/ATE407148T1/de
Priority to PCT/SE2001/002908 priority patent/WO2002053595A1/en
Priority to CA2429636A priority patent/CA2429636C/en
Priority to DK01273005T priority patent/DK1351988T3/da
Priority to SI200130880T priority patent/SI1351988T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE0004892A 2000-12-29 2000-12-29 Group 2 allergen specific IgE-Fabs and use thereof SE0004892D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0004892A SE0004892D0 (sv) 2000-12-29 2000-12-29 Group 2 allergen specific IgE-Fabs and use thereof
US10/027,725 US7288381B2 (en) 2000-12-29 2001-12-21 Group 2 allergen specific IgE-Fabs and use thereof
SI200130880T SI1351988T1 (sl) 2000-12-29 2001-12-27 IgG-molekule, specifične za alergene skupine 2, in njihova uporaba
JP2002555117A JP2004532813A (ja) 2000-12-29 2001-12-27 第２群アレルゲンに特異的なＩｇＥ−ＦａｂおよびＩｇＧ分子ならびにそれらの使用
DE60135677T DE60135677D1 (de) 2000-12-29 2001-12-27 Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung
EP01273005A EP1351988B1 (en) 2000-12-29 2001-12-27 Group 2 allergen specific igg molecules and use thereof
ES01273005T ES2315259T3 (es) 2000-12-29 2001-12-27 Moleculas de igg especificas para alergenos del grupo 2 y uso de las mismas.
AT01273005T ATE407148T1 (de) 2000-12-29 2001-12-27 Gruppe-2-allergen-spezifische igg-moleküle und deren verwendung
PCT/SE2001/002908 WO2002053595A1 (en) 2000-12-29 2001-12-27 Group 2 allergen specific ige-fabs and igg molecules and use thereof
CA2429636A CA2429636C (en) 2000-12-29 2001-12-27 Group 2 allergen specific ige-fabs and igg molecules and use thereof
DK01273005T DK1351988T3 (da) 2000-12-29 2001-12-27 IgG-molekyler specifikke for allergener fra gruppe 2 og anvendelse heraf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004892A SE0004892D0 (sv) 2000-12-29 2000-12-29 Group 2 allergen specific IgE-Fabs and use thereof

Publications (1)

Publication Number Publication Date
SE0004892D0 true SE0004892D0 (sv) 2000-12-29

Family

ID=20282467

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004892A SE0004892D0 (sv) 2000-12-29 2000-12-29 Group 2 allergen specific IgE-Fabs and use thereof

Country Status (10)

Country Link
EP (1) EP1351988B1 (xx)
JP (1) JP2004532813A (xx)
AT (1) ATE407148T1 (xx)
CA (1) CA2429636C (xx)
DE (1) DE60135677D1 (xx)
DK (1) DK1351988T3 (xx)
ES (1) ES2315259T3 (xx)
SE (1) SE0004892D0 (xx)
SI (1) SI1351988T1 (xx)
WO (1) WO2002053595A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1718974A2 (en) * 2004-02-26 2006-11-08 Alk-Abell A/S Method of evaluating the therapeutic potential of a vaccine for mucosal administration
AU2006287336A1 (en) * 2005-09-09 2007-03-15 The University Of Chicago Methods and compositions for diagnosis and immunotherapy of pollen allergy
WO2015185767A1 (es) * 2014-06-04 2015-12-10 Abbcn, S.L. Etiquetas peptídicas para el marcaje de proteínas por fusión, y anticuerpos para su detección

Also Published As

Publication number Publication date
CA2429636C (en) 2013-02-05
ES2315259T3 (es) 2009-04-01
JP2004532813A (ja) 2004-10-28
DK1351988T3 (da) 2009-01-12
EP1351988B1 (en) 2008-09-03
DE60135677D1 (de) 2008-10-16
ATE407148T1 (de) 2008-09-15
CA2429636A1 (en) 2002-07-11
SI1351988T1 (sl) 2009-02-28
WO2002053595A1 (en) 2002-07-11
EP1351988A1 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
ATE532860T1 (de) B7-ähnliche moleküle und deren anwendungen
EA200201214A1 (ru) Замещенные тиоацетамиды
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
EA200201247A1 (ru) Соединения для лечения болезни альцгеймера
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20005888D0 (no) Benzimidale derivater som mudulatorer av IgE
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
CA2424664A1 (en) Novel non-imidazole compounds
HUP0400659A2 (hu) Kitinázokkal, kitinázszerű molekulákkal és gyulladásos megbetegedéssel kapcsolatos eljárások, készítmények és reagenskészletek
AT500379A3 (de) Tau-proteine
WO2000053776A3 (en) Human kallikrein-like genes
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
SE0004892D0 (sv) Group 2 allergen specific IgE-Fabs and use thereof
ATE297408T1 (de) Verfahren zur isolierung und aufreinigung von gräserpollenallergenen
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
DK1639110T3 (da) Rajgræspollenspecifikke promotorer og ekspressionskonstructer
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
TR200402685T4 (tr) Merkezi sinir sistemi üzerine etki eden siklobüta-indol karboksamid türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler.
HUP0203689A2 (hu) Interleukin-1 receptor antagonistaszerű molekulák és ezek használata
ATE244714T1 (de) 1-(3-aminoindazol-5-yl)-3-phenylmethyl cyclische harnstoffe und ihre verwendung als hiv protease inhibitoren
ATE474848T1 (de) Neues pollen allergen